Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00429702 · ClinicalTrials.gov registry record · Phase 2
Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
A Phase 2 study, sponsored by University of South Florida.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00429702 is a Phase 2 study that was terminated before completion, run by University of South Florida. The registered enrollment target is 7 participants.
The verdict
NCT00429702, a Phase 2 study, was terminated before completion, sponsored by University of South Florida.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
RATIONALE: Diphenhydramine, lorazepam, and dexamethasone may help lessen or prevent nausea and vomiting in patients treated with chemotherapy. It is not yet known whether diphenhydramine, lorazepam, and dexamethasone are more effective than standard therapy in treating nausea and vomiting caused by chemotherapy. PURPOSE: This randomized phase II trial is studying diphenhydramine, lorazepam, and dexamethasone to see how well they work compared with standard therapy in treating nausea and vomiting caused by chemotherapy in young patients with newly diagnosed cancer.
Interventions
- DRUG Decadron®
- DRUG Benadryl®
- DRUG Ativan®
- DRUG ondansetron hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00429702
The ClinicalTrials.gov registry entry for NCT00429702 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Decadron® is the first listed.
NCT00429702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00429702 about?
NCT00429702 is a clinical study titled "Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy". RATIONALE: Diphenhydramine, lorazepam, and dexamethasone may help lessen or prevent nausea and vomiting in patients treated with chemotherapy. It is not yet known whether diphenhydramine, lorazepam, and dexamethasone are more effective than standard therapy in treating nausea and vomiting caused by ...
What is the current status of trial NCT00429702?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2007-10. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00429702?
The interventions under investigation include: Decadron® (DRUG), Benadryl® (DRUG), Ativan® (DRUG), ondansetron hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00429702?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.